SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Northrop Grumman Corp. engages in the provision of advanced aircraft systems. It operates through the following segments: Aeronautics Systems, Defense Systems, Mission Systems, and Space Systems. The Aeronautics Systems segment is involved in the design, development, production, integration, sustainment, and modernization of advanced aircraft systems for the U.S. Air Force, the U.S. Navy, other U.S. government agencies, and international customers. The Defense Systems segment includes integrated battle management systems, weapons systems and aircraft, and mission systems sustainment and modernization. The Mission Systems segment offers advanced mission solutions and multifunction systems, primarily for the U.S. defense and intelligence community, and international customers. The Space Systems segment delivers end-to-end mission solutions through the design, development, integration, production and operation of space, missile defense, launch and strategic missile systems for national security, civil government, commercial, and international customers. The company was founded by John K. Northrop, Thomas V. Jones, and Kent Kresa in 1939 and is headquartered in Falls Church, VA.

Northrop Grumman Corp.

Northrop Grumman is trending as investors digest a positive earnings report that showcased robust international sales and defense contract wins, helping the stock decouple from broader sector volatility. The community is actively discussing the company's solid execution in key missile and space programs, which contrast favorably against recent performance struggles faced by some of its primary defense peers.

Visa, Inc. engages in the provision of digital payment services. It also facilitates global commerce through the transfer of value and information among a global network of consumers, merchants, financial institutions, businesses, strategic partners, and government entities. It offers debit cards, credit cards, prepaid products, commercial payment solutions, and global automated teller machines. The company was founded by Dee Hock in 1958 and is headquartered in San Francisco, CA.

Visa Inc - Ordinary Shares - Class A

Visa Inc

Visa shares are facing significant volatility following recent political rhetoric regarding a proposed cap on credit card interest rates, sparking investor concern despite the firm's role as a payment network rather than a direct lender. The community is actively debating whether this selloff represents an irrational overreaction to political posturing or a fundamental threat to the long-term payment ecosystem, with many traders looking for reversal opportunities near key support levels.

Arm Holdings Plc engages in the licensing, marketing, research, and development of microprocessors, systems IP, graphics processing units, physical IP and associated systems IP, software, and tools. It operates through the following geographical segments: United Kingdom, United States, and Other Countries. The company was founded on November 12, 1990 and is headquartered in Cambridge, the United Kingdom.

Arm Holdings plc. - ADR

Arm Holdings Plc.

Arm Holdings is currently trending as investors debate its high valuation against long-term potential in AI server CPUs and the upcoming 'Arm Everywhere' event. While some community members remain wary of recent technical weakness and analyst price-target volatility, many are closely monitoring the stock as a key infrastructure play for the next wave of physical AI and data center demand.

BlockDAG is a hybrid concept that combines features of both traditional blockchains and DAGs. It retains the benefits of DAGs, such as high scalability and faster transaction processing, while integrating the security and trust of blockchain consensus mechanisms. BlockDAG emerges as a groundbreaking solution, meticulously merging the strengths of both blockchain and DAG architectures. It leverages the robust security and decentralization of blockchains while incorporating the efficient, scalable transaction processing of DAGs. This strategic integration allows blockDAG to handle a significantly higher volume of transactions at faster speeds compared to traditional blockchains. By overcoming the inherent limitations of both technologies, blockDAG paves the way for a future where distributed ledgers can seamlessly scale to meet the ever-growing demands of the cryptocurrency and broader digital landscape.

BlockDAG

BlockDAG is experiencing intense community scrutiny as investors grapple with restricted token access, failed claiming attempts, and concerns over the legitimacy of the project's development milestones. While some participants remain optimistic about the project's long-term potential, many active community members are venting frustrations over technical bugs and labels of potential scam activity.

The Charles Schwab Corp. is a savings and loan holding company, which engages in the provision of wealth management, securities brokerage, banking, asset management, custody, and financial advisory services. It operates through the Investor Services and Advisor Services segments. The Investor Services segment includes retail brokerage, investment advisory, and banking and trust services to individual investors, retirement plan and business services, as well as other corporate brokerage services, to businesses and employees. The Advisor Services segment provides custodial, trading, banking and trust, and support services to independent registered investment advisors, independent retirement advisors, and recordkeepers. The company was founded by Charles Robert Schwab in 1986 and is headquartered in Westlake, TX.

Charles Schwab Corp.

Charles Schwab is trending as investors digest a series of mixed monthly asset growth reports and navigate broader financial sector volatility linked to changing interest rate expectations. The community is actively discussing the platform's trading limitations and service reliability compared to emerging competitors, while analysts continue to weigh the firm's strategic push into private markets against fears of fee compression from AI-driven financial tools.

Wells Fargo & Co. is a diversified and community-based financial services company, which engages in the provision of banking, insurance, investments, mortgage, and consumer and commercial finance products and services. It operates through the following segments: Consumer Banking and Lending, Commercial Banking, Corporate and Investment Banking, and Wealth and Investment Management. The Consumer Banking and Lending segment offers consumer and small business banking, home lending, credit cards, auto, and personal lending. The Commercial Banking segment provides banking and credit products across industry sectors and municipalities, secured lending and lease products, and treasury management. The Corporate and Investment Banking segment is composed of corporate banking, investment banking, treasury management, commercial real estate lending and servicing, and equity and fixed income solutions, as well as sales, trading, and research capabilities. The Wealth and Investment Management segment refers to personalized wealth management, brokerage, financial planning, lending, private banking, trust, and fiduciary products and services. The company was founded by Henry Wells and William G. Fargo on March 18, 1852 and is headquartered in San Francisco, CA.

Wells Fargo & Co.

Wells Fargo is trending following a third-quarter earnings beat and an upward revision to its profitability targets, a move fueled by the recent removal of its long-standing asset cap. Investors and analysts are actively discussing the bank's transition into a growth phase, focusing on its ability to expand balance sheet operations and leverage efficiency gains from its simplified cost structure.

Rithm Capital Corp. engages in the provision of real estate, credit, and financial services. It operates through the following segments: Origination and Servicing, Investment Portfolio, Residential Transitional Lending, Asset Management, and Corporate. The Origination and Servicing segment includes residential mortgage loans underlying mortgage servicing right assets as well as those sub-service for third parties. The Investment Portfolio segment consists of residential mortgage loans, SFR properties, consumer loans, Non-Agency RMBS, Excess MSRs and servicer advance investments. The Residential Transitional Lending segment competes for both experienced sponsors, including developers and investors in residential real estate, and attractive lending opportunities based on several factors. The Asset Management segment focuses on the wholly owned subsidiaries, Sculptor, and RCM Manager. The company was founded on September 26, 2011 and is headquartered in New York, NY.

Rithm Capital Corporation

Rithm Capital is currently in the spotlight as investors react to its strategic acquisition of Paramount Groups office portfolio and the firm's ongoing transition toward a diversified alternative asset manager. The community is actively debating the impact of these expansion efforts on future dividend sustainability, with many traders closely monitoring the firm's evolving business model as a catalyst for potential long-term value unlocking.

Caterpillar, Inc. engages in the business of manufacturing construction and mining equipment, off-highway diesel and natural gas engines, industrial gas turbines, and diesel-electric locomotives. It operates through the following segments: Construction Industries, Resource Industries, Energy and Transportation, Financial Products, and All Other. The Construction Industries segment is involved in supporting customers using machinery in infrastructure and building construction applications. The Resource Industries segment offers machinery in mining, heavy construction, quarry, and aggregates. The Energy and Transportation segment focuses on reciprocating engines, turbines, diesel-electric locomotives, and related services across industries serving oil and gas, power generation, industrial, and transportation applications including marine- and rail-related businesses. The Financial Products segment provides financing alternatives to customers and dealers for Caterpillar products and services, as well as financing for power generation facilities. The All Other segment includes activities such as the business strategy, product management and development, manufacturing, and sourcing of wear and maintenance components products, parts distribution, integrated logistics solutions, distribution services responsible for dealer development, and administration. The company was founded on April 15, 1925 and is headquartered in Irving, TX.

Caterpillar Inc.

Caterpillar is trending as investors debate its valuation amidst a shift toward AI-driven data center power demand and heavy infrastructure spending. While some community members highlight the stock's impressive long-term performance and status as an industrial powerhouse, others are expressing caution, citing technical overextension and potential risks from tariff headwinds.

Deere & Co. engages in the manufacture and distribution of equipment used in agriculture, construction, forestry, and turf care. It operates through the following segments: Agriculture and Turf, Construction and Forestry, and Financial Services. The Agriculture and Turf segment focuses on the distribution and manufacture of a full line of agriculture and turf equipment and related service parts. The Construction and Forestry segment offers machines and service parts used in construction, earthmoving, road building, material handling and timber harvesting. The Financial Services segment finances sales and leases by John Deere dealers of new and used agriculture and turf equipment and construction and forestry equipment. The company was founded by John Deere in 1837 and is headquartered in Moline, IL.

Deere & Co.

Deere & Co

Deere & Co is facing intense scrutiny as investors weigh heavy cyclical headwinds, including high input costs, tariff uncertainty, and weakening agricultural equipment demand, against the firm's premium valuation. While the community is debating whether the company can successfully navigate these macro pressures through innovation or if the stock is primed for a pullback, active discussions are focused on the impact of shifting farmer sentiment and the sustainability of current profit margins.

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.

Abbvie Inc

AbbVie is attracting attention as investors weigh a strong growth trajectory fueled by top-selling immunology drugs against recent volatility driven by news-cycle speculation. The community is actively debating the company's valuation and strategic positioning, particularly as traders monitor potential M&A activity within the broader biopharma sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Top Biotech Stocks To Follow Today - March 17th

Vertex Pharmaceuticals, bioAffinity Technologies, Lunai Bioworks, Danaher, Moderna, ImmunityBio, and argenex are the seven Biotech stocks to watch today, according to MarketBeat's stock screener...

Small Caps Surge on Breakouts, Biotech Validation, and “Real-World” Tech Adoption

Momentum is building across small-cap names this week, with a mix of technical breakouts, clinical validation, and commercialization milestones driving a more constructive tone beneath the surface of the market. $LNAI, $BIAF, $IBRX, $KBLB, $UCAR, $LIDR, $JTAI, $FLYX

<ul class="summary-bullets"><li>BioAffinity tested CyPath Lung on a 71-year-old former smoker with multiple lung nodules.</li><li>The non-invasive test confirmed that the lung nodules were likely due to inflammation rather than cancer.</li><li>CyPath Lung test uses advanced testing and artificial intelligence to analyze cells in a patient’s sputum.</li></ul>Shares of BioAffinity Technologies (BIAF) popped nearly 40% on Tuesday, after the biotech company shared a positive update from a new case study evaluating its non-invasive CyPath Lung test in evaluating lung cancer risk.BioAffinity used the CyPath Lung test on a 71-year-old former smoker with multiple lung nodules, a condition that often leads to invasive procedures.“In this case, the patient’s CyPath Lung result was negative, indicating a low likelihood of malignancy, and together both the patient and I were comfortable in waiting for a follow-up CT scan in three months,” said Daya Nadarajah, MD, the patient’s pulmonologist.Follow-up CT scans showed that the suspicious nodules had resolved, confirming they were likely due to inflammation rather than cancer. CyPath Lung test uses advanced testing and artificial intelligence to analyze cells in a patient’s sputum and detect signs that could suggest cancer.<h2 class="st-heading-2">Record CyPath Lung Revenue&nbsp;</h2>On March 13, 2026, BIAF shares closed 98% higher after the company reported an 87% increase in full-year (FY) 2025 revenue from CyPath Lung, with test volumes rising 99%.Its FY25 revenue fell to $6.2 million from $9.4 million in 2024, as it exited unprofitable services to focus on CyPath Lung. Net loss widened to $14.9 million, mainly due to higher clinical development costs, expanded sales efforts, and changes in warrant valuations.&nbsp;The company also raised $16.9 million to support growth. Looking ahead, it expects CyPath Lung unit sales to more than double in 2026, driving higher revenue.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Retail sentiment for <a href="https://stocktwits.com/symbol/BIAF">BIAF</a> on Stocktwits has remained ‘extremely bullish’ over the past week, amid ‘extremely high’ message volumes.<img src="https://news.stocktwits-cdn.com/BIAF_jpg_6b2f0f777c.webp" alt="BIAF.jpg">One user said that trading in the stock is a “long term play.”<stembedurl>https://stocktwits.com/MicrocapCowboy/message/647734591</stembedurl>Another user expects the stock to breach its $3 resistance.<stembedurl>https://stocktwits.com/brallt/message/647730923</stembedurl>Around 100 million shares changed hands at the time of writing, well above the average of 0.3 million, according to Stocktwits data.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Representative image of a trending stock chart.

Why Did BIAF Stock Surge 40% Today?

Shares of BioAffinity Technologies (BIAF) popped around 20% in pre-market trading on Tuesday, after the biotech company shared a positive update from a new case study evaluating its non-invasive CyPath Lung test in evaluating lung cancer risk.

Equity

The stock jumped on heavy volume after a positive update tied to its AI-driven lung cancer screening test.

Case Study Highlights How CyPath Lung Helps Patients Avoid Invasive Procedures

bioAffinity Technologies (NASDAQ:BIAF) released a new clinical case study demonstrating how its noninvasive diagnostic test, CyPath Lung, can help physicians make more confident decisions while sparing patients from unnecessary invasive procedures.

New Case Study: bioAffinity Technologies CyPath Lung Provides Actionable Results and Helps Patient Avoid Costly, Invasive Procedures

bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company advancing noninvasive diagnostics for lung cancer and other lung diseases, today released a new clinical case study that...

Best Small Cap Stocks To Add to Your Watchlist - March 15th

Direxion Daily MU Bull 2X Shares, bioAffinity Technologies, Direxion Daily PLTR Bear 1X Shares, Vale, and AltC Acquisition are the five Small Cap stocks to watch today, according to MarketBeat's...

Promising Biotech Stocks To Add to Your Watchlist - March 15th

Danaher, Vertex Pharmaceuticals, bioAffinity Technologies, Moderna, United Therapeutics, ImmunityBio, and argenex are the seven Biotech stocks to watch today, according to MarketBeat's stock screener...

Promising Small Cap Stocks To Consider - March 14th

Direxion Daily MU Bull 2X Shares, bioAffinity Technologies, Direxion Daily PLTR Bear 1X Shares, Vale, AltC Acquisition, PAYP, and Direxion Daily AMD Bear 1X Shares are the seven Small Cap stocks to...

Biotech Stocks To Watch Now - March 14th

Danaher, Vertex Pharmaceuticals, and bioAffinity Technologies are the three Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech stocks are shares of companies that...

Small Cap Stocks To Follow Today - March 13th

Direxion Daily MU Bull 2X Shares, bioAffinity Technologies, and Direxion Daily PLTR Bear 1X Shares are the three Small Cap stocks to watch today, according to MarketBeat's stock screener tool...

bioAffinity Technologies, Inc. operates as a development-stage company addressing the significant unmet need for non-invasive, early-stage cancer diagnosis and treatment. The firm develops proprietary in-vitro diagnostic tests and targeted cancer therapeutics using breakthrough technology that preferentially targets cancer cells. The company was founded on March 26, 2014 and is headquartered in San Antonio, TX.

BIAF
BioAffinity Technologies Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest BIAF News

BIAFBioAffinity Technologies Inc